BioSig Technologies, Inc.
  • Home
  • About BioSig
    • About BioSig
    • Overview
    • Partnerships
  • Our Technology
    • Our Technology
    • The PURE EP Platform
      • Overview
      • ATC
      • NFT
    • Publications
  • Join Our Team
  • News & Media
    • News & Media
    • Overview
    • Press Releases
    • BioSig in the News
    • Events
  • Investors
    • Investors
    • Overview
    • News / Events
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Information
      • Profile
      • Leadership Team
      • Contacts
      • FAQ
    • Financial Information
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Financial Results
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Corporate Governance
      • Board of Directors
      • Governance Documents
  • Contact
Investors

Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Profile
    • Leadership Team
    • Contacts
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Contacts
    • RSS News Feed

Press Releases

  • News / Events

  • Press Releases
  • IR Calendar
  • Email Alerts

BioSig Enters into an LOI to Merge with Streamex Exchange Corp. Creating a Publicly Listed Real-World Asset Tokenization Company Led by Seasoned Industry Executives

May 5, 2025

BioSig Technologies Confirms Full Compliance with Nasdaq Requirements for Continued Listing on The Nasdaq Capital Market

March 26, 2025

BioSig Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

November 13, 2024

BioSig Technologies’ Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel

October 22, 2024

BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation

July 31, 2024

BioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables during Q2 2024

July 25, 2024

BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer

June 10, 2024

BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

May 30, 2024

BioSig Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

May 30, 2024

BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders

May 21, 2024
rss_feed News RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...36
Next
Award
BioSig Technologies, Inc.
Sign Up for BioSig Updates Contact Us
x formerly known as twitter icon X formerly known as Twitter
linkedin Facebook
© 2025 BioSig Technologies, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap